Resolution of Ocular Involvement With Systemic Eculizumab Therapy in Atypical Hemolytic-Uremic Syndrome

Eye - United Kingdom
doi 10.1038/eye.2013.111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Eculizumab in Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine
Medicine
2013English

Skin Involvement in Atypical Hemolytic Uremic Syndrome

American Journal of Kidney Diseases
Nephrology
2014English

Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation

Kidney Medicine
Internal MedicineNephrology
2019English

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome

Kidney International Reports
Nephrology
2019English

Atypical Hemolytic-Uremic Syndrome

2020English

Transplantation in Atypical Hemolytic Uremic Syndrome

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2010English

Ocular Thrombotic Microangiopathy in Atypical Hemolytic-Uremic Syndrome (A Clinical Case Study)

Vestnik Oftalmologii
MedicineOphthalmology
2018English

The Genetics of Atypical Hemolytic Uremic Syndrome

Medizinische Genetik
Genetics
2018English

Genetics of Atypical Hemolytic Uremic Syndrome (aHUS)

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy